Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients

Pál Brasnyó, Gergo A. Molnár, M. Mohás, Lajos Markó, Boglárka Laczy, Judit Cseh, Esztella Mikolás, István András Szijártó, Ákos Mérei, Richárd Halmai, László G. Mészáros, B. Sümegi, I. Wittmann

Research output: Contribution to journalArticle

349 Citations (Scopus)

Abstract

Although resveratrol has widely been studied for its potential health benefits, little is known about its metabolic effects in humans. Our aims were to determine whether the polyphenol resveratrol improves insulin sensitivity in type 2 diabetic patients and to gain some insight into the mechanism of its action. After an initial general examination (including blood chemistry), nineteen patients enrolled in the 4-week-long double-blind study were randomly assigned into two groups: a resveratrol group receiving oral 2 Ã-5 mg resveratrol and a control group receiving placebo. Before and after the second and fourth weeks of the trial, insulin resistance/sensitivity, creatinine-normalised ortho-tyrosine level in urine samples (as a measure of oxidative stress), incretin levels and phosphorylated protein kinase B (pAkt):protein kinase B (Akt) ratio in platelets were assessed and statistically analysed. After the fourth week, resveratrol significantly decreased insulin resistance (homeostasis model of assessment for insulin resistance) and urinary ortho-tyrosine excretion, while it increased the pAkt:Akt ratio in platelets. On the other hand, it had no effect on parameters that relate to 1β-cell function (i.e. homeostasis model of assessment of 1β-cell function). The present study shows for the first time that resveratrol improves insulin sensitivity in humans, which might be due to a resveratrol-induced decrease in oxidative stress that leads to a more efficient insulin signalling via the Akt pathway.

Original languageEnglish
Pages (from-to)383-389
Number of pages7
JournalBritish Journal of Nutrition
Volume106
Issue number3
DOIs
Publication statusPublished - Aug 14 2011

Fingerprint

Insulin Resistance
Oxidative Stress
Proto-Oncogene Proteins c-akt
Homeostasis
Blood Platelets
Incretins
Polyphenols
Insurance Benefits
resveratrol
Double-Blind Method
Creatinine
Placebos
Urine
Insulin
Control Groups

Keywords

  • Akt
  • Insulin sensitivity
  • Oxidative stress
  • Resveratrol
  • Type 2 diabetes

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics
  • Medicine(all)

Cite this

Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. / Brasnyó, Pál; Molnár, Gergo A.; Mohás, M.; Markó, Lajos; Laczy, Boglárka; Cseh, Judit; Mikolás, Esztella; Szijártó, István András; Mérei, Ákos; Halmai, Richárd; Mészáros, László G.; Sümegi, B.; Wittmann, I.

In: British Journal of Nutrition, Vol. 106, No. 3, 14.08.2011, p. 383-389.

Research output: Contribution to journalArticle

Brasnyó, P, Molnár, GA, Mohás, M, Markó, L, Laczy, B, Cseh, J, Mikolás, E, Szijártó, IA, Mérei, Á, Halmai, R, Mészáros, LG, Sümegi, B & Wittmann, I 2011, 'Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients', British Journal of Nutrition, vol. 106, no. 3, pp. 383-389. https://doi.org/10.1017/S0007114511000316
Brasnyó, Pál ; Molnár, Gergo A. ; Mohás, M. ; Markó, Lajos ; Laczy, Boglárka ; Cseh, Judit ; Mikolás, Esztella ; Szijártó, István András ; Mérei, Ákos ; Halmai, Richárd ; Mészáros, László G. ; Sümegi, B. ; Wittmann, I. / Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. In: British Journal of Nutrition. 2011 ; Vol. 106, No. 3. pp. 383-389.
@article{21ecba51ada74bba82bbf2d7f07fb24f,
title = "Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients",
abstract = "Although resveratrol has widely been studied for its potential health benefits, little is known about its metabolic effects in humans. Our aims were to determine whether the polyphenol resveratrol improves insulin sensitivity in type 2 diabetic patients and to gain some insight into the mechanism of its action. After an initial general examination (including blood chemistry), nineteen patients enrolled in the 4-week-long double-blind study were randomly assigned into two groups: a resveratrol group receiving oral 2 {\~A}-5 mg resveratrol and a control group receiving placebo. Before and after the second and fourth weeks of the trial, insulin resistance/sensitivity, creatinine-normalised ortho-tyrosine level in urine samples (as a measure of oxidative stress), incretin levels and phosphorylated protein kinase B (pAkt):protein kinase B (Akt) ratio in platelets were assessed and statistically analysed. After the fourth week, resveratrol significantly decreased insulin resistance (homeostasis model of assessment for insulin resistance) and urinary ortho-tyrosine excretion, while it increased the pAkt:Akt ratio in platelets. On the other hand, it had no effect on parameters that relate to 1β-cell function (i.e. homeostasis model of assessment of 1β-cell function). The present study shows for the first time that resveratrol improves insulin sensitivity in humans, which might be due to a resveratrol-induced decrease in oxidative stress that leads to a more efficient insulin signalling via the Akt pathway.",
keywords = "Akt, Insulin sensitivity, Oxidative stress, Resveratrol, Type 2 diabetes",
author = "P{\'a}l Brasny{\'o} and Moln{\'a}r, {Gergo A.} and M. Moh{\'a}s and Lajos Mark{\'o} and Bogl{\'a}rka Laczy and Judit Cseh and Esztella Mikol{\'a}s and Szij{\'a}rt{\'o}, {Istv{\'a}n Andr{\'a}s} and {\'A}kos M{\'e}rei and Rich{\'a}rd Halmai and M{\'e}sz{\'a}ros, {L{\'a}szl{\'o} G.} and B. S{\"u}megi and I. Wittmann",
year = "2011",
month = "8",
day = "14",
doi = "10.1017/S0007114511000316",
language = "English",
volume = "106",
pages = "383--389",
journal = "British Journal of Nutrition",
issn = "0007-1145",
publisher = "Cambridge University Press",
number = "3",

}

TY - JOUR

T1 - Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients

AU - Brasnyó, Pál

AU - Molnár, Gergo A.

AU - Mohás, M.

AU - Markó, Lajos

AU - Laczy, Boglárka

AU - Cseh, Judit

AU - Mikolás, Esztella

AU - Szijártó, István András

AU - Mérei, Ákos

AU - Halmai, Richárd

AU - Mészáros, László G.

AU - Sümegi, B.

AU - Wittmann, I.

PY - 2011/8/14

Y1 - 2011/8/14

N2 - Although resveratrol has widely been studied for its potential health benefits, little is known about its metabolic effects in humans. Our aims were to determine whether the polyphenol resveratrol improves insulin sensitivity in type 2 diabetic patients and to gain some insight into the mechanism of its action. After an initial general examination (including blood chemistry), nineteen patients enrolled in the 4-week-long double-blind study were randomly assigned into two groups: a resveratrol group receiving oral 2 Ã-5 mg resveratrol and a control group receiving placebo. Before and after the second and fourth weeks of the trial, insulin resistance/sensitivity, creatinine-normalised ortho-tyrosine level in urine samples (as a measure of oxidative stress), incretin levels and phosphorylated protein kinase B (pAkt):protein kinase B (Akt) ratio in platelets were assessed and statistically analysed. After the fourth week, resveratrol significantly decreased insulin resistance (homeostasis model of assessment for insulin resistance) and urinary ortho-tyrosine excretion, while it increased the pAkt:Akt ratio in platelets. On the other hand, it had no effect on parameters that relate to 1β-cell function (i.e. homeostasis model of assessment of 1β-cell function). The present study shows for the first time that resveratrol improves insulin sensitivity in humans, which might be due to a resveratrol-induced decrease in oxidative stress that leads to a more efficient insulin signalling via the Akt pathway.

AB - Although resveratrol has widely been studied for its potential health benefits, little is known about its metabolic effects in humans. Our aims were to determine whether the polyphenol resveratrol improves insulin sensitivity in type 2 diabetic patients and to gain some insight into the mechanism of its action. After an initial general examination (including blood chemistry), nineteen patients enrolled in the 4-week-long double-blind study were randomly assigned into two groups: a resveratrol group receiving oral 2 Ã-5 mg resveratrol and a control group receiving placebo. Before and after the second and fourth weeks of the trial, insulin resistance/sensitivity, creatinine-normalised ortho-tyrosine level in urine samples (as a measure of oxidative stress), incretin levels and phosphorylated protein kinase B (pAkt):protein kinase B (Akt) ratio in platelets were assessed and statistically analysed. After the fourth week, resveratrol significantly decreased insulin resistance (homeostasis model of assessment for insulin resistance) and urinary ortho-tyrosine excretion, while it increased the pAkt:Akt ratio in platelets. On the other hand, it had no effect on parameters that relate to 1β-cell function (i.e. homeostasis model of assessment of 1β-cell function). The present study shows for the first time that resveratrol improves insulin sensitivity in humans, which might be due to a resveratrol-induced decrease in oxidative stress that leads to a more efficient insulin signalling via the Akt pathway.

KW - Akt

KW - Insulin sensitivity

KW - Oxidative stress

KW - Resveratrol

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=80052910300&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052910300&partnerID=8YFLogxK

U2 - 10.1017/S0007114511000316

DO - 10.1017/S0007114511000316

M3 - Article

C2 - 21385509

AN - SCOPUS:80052910300

VL - 106

SP - 383

EP - 389

JO - British Journal of Nutrition

JF - British Journal of Nutrition

SN - 0007-1145

IS - 3

ER -